A quarter century has passed since the milestone study by Mazzaferro and colleagues on
liver transplantation (LT) for hepatocellular carcinoma (HCC). 1 The increasing demand for …

Initial concerns about graft rejection, with ICIs as a bridging therapy to liver transplantation,
were successfully addressed using adequate immunosuppressants strategies and …

Immune checkpoint inhibitors (ICIs) have emerged as the primary treatment for advanced
hepatocellular carcinoma (HCC) and have shown promise in the neoadjuvant setting prior to …

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape for
advanced hepatocellular carcinoma (HCC). The combination of Atezolizumab and …

Simple Summary Immune checkpoint inhibitors (ICIs) have witnessed significant success in
systemic therapy of hepatocellular carcinoma, stimulating the transplant community to …

The first liver transplant, performed by Dr Thomas Starzl in 1967, used a combination of
azathioprine, steroids, and heterolygous antilymphocyte globulin (ALG) for …

In Reply Thank you for the opportunity to reply to the Letters to the Editor submitted by Yu
and Wei and by Huang on our recently published article comparing robotic and open liver …

Hepatocellular carcinoma, the most prevalent malignant liver tumor, is typically
characterized by a low early detection rate and a poor 5-year overall survival rate. Liver …